Leptin
Latest Information Update: 25 Sep 2021
Price :
$50 *
At a glance
- Originator Howard Hughes Medical Institute; Nonindustrial source; Rockefeller University
- Developer Nonindustrial source
- Class Adipokines; Anorectics; Antihyperglycaemics; Obesity therapies; Peptide hormones; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Vascular disorders
- Discontinued Obesity; Type 2 diabetes mellitus
Most Recent Events
- 02 Nov 2005 No development reported - Preclinical for Vascular disorders in USA (unspecified route)
- 13 Jun 2002 This compound is still in active development
- 28 Apr 1999 Discontinued-II for Obesity in USA (SC)